Biodesix, Inc. (BDSX)
24.58
+0.59
(+2.46%)
USD |
NASDAQ |
Oct 15, 16:00
24.58
0.00 (0.00%)
After-Hours: 18:20
Biodesix Total Long Term Debt (Quarterly) : 70.19M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 70.19M |
| March 31, 2026 | 70.16M |
| December 31, 2025 | 71.49M |
| September 30, 2025 | 71.53M |
| June 30, 2025 | 70.91M |
| March 31, 2025 | 61.19M |
| December 31, 2024 | 61.26M |
| September 30, 2024 | 61.33M |
| June 30, 2024 | 61.32M |
| March 31, 2024 | 60.90M |
| December 31, 2023 | 60.44M |
| September 30, 2023 | 49.64M |
| June 30, 2023 | 43.52M |
| March 31, 2023 | 37.17M |
| Date | Value |
|---|---|
| December 31, 2022 | 30.31M |
| September 30, 2022 | 22.07M |
| June 30, 2022 | 23.27M |
| March 31, 2022 | 11.28M |
| December 31, 2021 | 10.01M |
| September 30, 2021 | 30.00M |
| June 30, 2021 | 33.06M |
| March 31, 2021 | 33.04M |
| December 31, 2020 | 27.77M |
| September 30, 2020 | 54.14M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 35.97M |
| September 30, 2019 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Quest Diagnostics, Inc. | 6.203B |
| Labcorp Holdings, Inc. | 6.586B |
| OPKO Health, Inc. | 387.07M |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | 444.65M |